RecruitingNot ApplicableNCT05390424
Screening for Hepatitis B, Hepatitis C and AIDS Viruses Using Dried Blood Spot
Sponsor
University Hospital, Rouen
Enrollment
500 participants
Start Date
Dec 2, 2022
Study Type
INTERVENTIONAL
Conditions
Summary
The aim of the study is to screen for hepatitis B, hepatitis C and AIDS viruses using a Dried Blood Spot in drug users
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- Former or active intravenous and/or nasal drug user
- Person on opiate substitution therapy
Exclusion Criteria1
- Person with known active viral infection(s)
Interventions
DIAGNOSTIC_TESTBlood collection using Dried Blood Spot
Drug users will be screened for Hepatitis C, Hepatitis B and AIDS using Dried Blood Spot for blood collection
Locations(11)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05390424
Related Trials
A Randomized Clinical Trial to Evaluate Solutions for the Management of Virologic Failure on TLD in Sub-Saharan Africa
NCT053737583 locations
The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
NCT012808251 location
The DC Cohort Longitudinal HIV Status Neutral Study
NCT0120692014 locations
The Hepatitis C Transplant Collaborative
NCT044933851 location
C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV
NCT0703727789 locations